{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T08:25:14Z","timestamp":1785486314890,"version":"3.56.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1038\/s41375-019-0614-6","type":"journal-article","created":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T18:03:40Z","timestamp":1572631420000},"page":"746-758","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["LSD1-mediated repression of GFI1 super-enhancer plays an essential role in erythroleukemia"],"prefix":"10.1038","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5886-2381","authenticated-orcid":false,"given":"Goichi","family":"Tatsumi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2721-7571","authenticated-orcid":false,"given":"Masahiro","family":"Kawahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryusuke","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakatsu","family":"Hishizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuyuki","family":"Kito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2439-879X","authenticated-orcid":false,"given":"Takayoshi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7678-4284","authenticated-orcid":false,"given":"Akifumi","family":"Takaori-Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Andoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,1]]},"reference":[{"key":"614_CR1","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/ncb2709","volume":"15","author":"V Moignard","year":"2013","unstructured":"Moignard V, Macaulay IC, Swiers G, Buettner F, Schutte J, Calero-Nieto FJ, et al. Characterization of transcriptional networks in blood stem and progenitor cells using high-throughput single-cell gene expression analysis. Nat Cell Biol. 2013;15:363\u201372.","journal-title":"Nat Cell Biol"},{"key":"614_CR2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nrc989","volume":"3","author":"DG Tenen","year":"2003","unstructured":"Tenen DG. Disruption of differentiation in human cancer: AML shows the way. Nat Rev Cancer. 2003;3:89\u2013101.","journal-title":"Nat Rev Cancer"},{"key":"614_CR3","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1126\/science.1256271","volume":"345","author":"D Lara-Astiaso","year":"2014","unstructured":"Lara-Astiaso D, Weiner A, Lorenzo-Vivas E, Zaretsky I, Jaitin DA, David E, et al. Immunogenetics. Chromatin state dynamics during blood formation. Science. 2014;345:943\u20139.","journal-title":"Science"},{"key":"614_CR4","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.cell.2013.03.035","volume":"153","author":"WA Whyte","year":"2013","unstructured":"Whyte WA, Orlando DA, Hnisz D, Abraham BJ, Lin CY, Kagey MH, et al. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell. 2013;153:307\u201319.","journal-title":"Cell"},{"key":"614_CR5","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.molcel.2013.01.038","volume":"49","author":"E Calo","year":"2013","unstructured":"Calo E, Wysocka J. Modification of enhancer chromatin: what, how, and why? Mol Cell. 2013;49:825\u201337.","journal-title":"Mol Cell"},{"key":"614_CR6","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.stem.2016.08.004","volume":"19","author":"B Aranda-Orgilles","year":"2016","unstructured":"Aranda-Orgilles B, Saldana-Meyer R, Wang E, Trompouki E, Fassl A, Lau S, et al. MED12 regulates HSC-specific enhancers independently of mediator kinase activity to control hematopoiesis. Cell Stem Cell. 2016;19:784\u201399.","journal-title":"Cell Stem Cell"},{"key":"614_CR7","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.cell.2013.09.053","volume":"155","author":"D Hnisz","year":"2013","unstructured":"Hnisz D, Abraham BJ, Lee TI, Lau A, Saint-Andre V, Sigova AA, et al. Super-enhancers in the control of cell identity and disease. Cell. 2013;155:934\u201347.","journal-title":"Cell"},{"key":"614_CR8","doi-asserted-by":"publisher","first-page":"17921","DOI":"10.1073\/pnas.1317023110","volume":"110","author":"SC Parker","year":"2013","unstructured":"Parker SC, Stitzel ML, Taylor DL, Orozco JM, Erdos MR, Akiyama JA, et al. Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants. Proc Natl Acad Sci USA. 2013;110:17921\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"614_CR9","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.molcel.2015.02.014","volume":"58","author":"D Hnisz","year":"2015","unstructured":"Hnisz D, Schuijers J, Lin CY, Weintraub AS, Abraham BJ, Lee TI, et al. Convergence of developmental and oncogenic signaling pathways at transcriptional super-enhancers. Mol Cell. 2015;58:362\u201370.","journal-title":"Mol Cell"},{"key":"614_CR10","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1038\/nm.3665","volume":"20","author":"D Herranz","year":"2014","unstructured":"Herranz D, Ambesi-Impiombato A, Palomero T, Schnell SA, Belver L, Wendorff AA, et al. A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia. Nat Med. 2014;20:1130\u20137.","journal-title":"Nat Med"},{"key":"614_CR11","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.cell.2014.02.019","volume":"157","author":"S Groschel","year":"2014","unstructured":"Groschel S, Sanders MA, Hoogenboezem R, de Wit E, Bouwman BAM, Erpelinck C, et al. A single oncogenic enhancer rearrangement causes concomitant EVI1 and GATA2 deregulation in leukemia. Cell. 2014;157:369\u201381.","journal-title":"Cell"},{"key":"614_CR12","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.cell.2004.12.012","volume":"119","author":"Y Shi","year":"2004","unstructured":"Shi Y, Lan F, Matson C, Mulligan P, Whetstine JR, Cole PA, et al. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell. 2004;119:941\u201353.","journal-title":"Cell"},{"key":"614_CR13","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.molcel.2005.08.027","volume":"19","author":"YJ Shi","year":"2005","unstructured":"Shi YJ, Matson C, Lan F, Iwase S, Baba T, Shi Y. Regulation of LSD1 histone demethylase activity by its associated factors. Mol Cell. 2005;19:857\u201364.","journal-title":"Mol Cell"},{"key":"614_CR14","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/nature04021","volume":"437","author":"MG Lee","year":"2005","unstructured":"Lee MG, Wynder C, Cooch N, Shiekhattar R. An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylation. Nature. 2005;437:432\u20135.","journal-title":"Nature"},{"key":"614_CR15","doi-asserted-by":"publisher","first-page":"21931","DOI":"10.1073\/pnas.1016071107","volume":"107","author":"MP Creyghton","year":"2010","unstructured":"Creyghton MP, Cheng AW, Welstead GG, Kooistra T, Carey BW, Steine EJ, et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc Natl Acad Sci USA. 2010;107:21931\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"614_CR16","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/nature14289","volume":"521","author":"RC Adam","year":"2015","unstructured":"Adam RC, Yang H, Rockowitz S, Larsen SB, Nikolova M, Oristian DS, et al. Pioneer factors govern super-enhancer dynamics in stem cell plasticity and lineage choice. Nature. 2015;521:366\u201370.","journal-title":"Nature"},{"key":"614_CR17","doi-asserted-by":"publisher","first-page":"e00633","DOI":"10.7554\/eLife.00633","volume":"2","author":"MA Kerenyi","year":"2013","unstructured":"Kerenyi MA, Shao Z, Hsu YJ, Guo G, Luc S, O\u2019Brien K, et al. Histone demethylase Lsd1 represses hematopoietic stem and progenitor cell signatures during blood cell maturation. eLife. 2013;2:e00633.","journal-title":"eLife"},{"key":"614_CR18","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.ccr.2012.03.014","volume":"21","author":"WJ Harris","year":"2012","unstructured":"Harris WJ, Huang X, Lynch JT, Spencer GJ, Hitchin JR, Li Y, et al. The histone demethylase KDM1A sustains the oncogenic potential of MLL-AF9 leukemia stem cells. Cancer Cell. 2012;21:473\u201387.","journal-title":"Cancer Cell"},{"key":"614_CR19","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1182\/blood-2014-04-569525","volume":"124","author":"D Niebel","year":"2014","unstructured":"Niebel D, Kirfel J, Janzen V, Holler T, Majores M, Gutgemann I. Lysine-specific demethylase 1 (LSD1) in hematopoietic and lymphoid neoplasms. Blood. 2014;124:151\u20132.","journal-title":"Blood"},{"key":"614_CR20","doi-asserted-by":"publisher","first-page":"3731","DOI":"10.1182\/blood-2014-11-610907","volume":"125","author":"T Wada","year":"2015","unstructured":"Wada T, Koyama D, Kikuchi J, Honda H, Furukawa Y. Overexpression of the shortest isoform of histone demethylase LSD1 primes hematopoietic stem cells for malignant transformation. Blood. 2015;125:3731\u201346.","journal-title":"Blood"},{"key":"614_CR21","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3389\/fonc.2018.00255","volume":"8","author":"D Magliulo","year":"2018","unstructured":"Magliulo D, Bernardi R, Messina S. Lysine-specific demethylase 1A as a promising target in acute myeloid leukemia. Front Oncol. 2018;8:255.","journal-title":"Front Oncol"},{"key":"614_CR22","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/nm.2661","volume":"18","author":"T Schenk","year":"2012","unstructured":"Schenk T, Chen WC, Gollner S, Howell L, Jin L, Hebestreit K, et al. Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia. Nat Med. 2012;18:605\u201311.","journal-title":"Nat Med"},{"key":"614_CR23","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1038\/leu.2017.59","volume":"31","author":"N Sugino","year":"2017","unstructured":"Sugino N, Kawahara M, Tatsumi G, Kanai A, Matsui H, Yamamoto R, et al. A novel LSD1 inhibitor NCD38 ameliorates MDS-related leukemia with complex karyotype by attenuating leukemia programs via activating super-enhancers. Leukemia. 2017;31:2303\u201314.","journal-title":"Leukemia"},{"key":"614_CR24","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.ccell.2018.02.002","volume":"33","author":"T Maes","year":"2018","unstructured":"Maes T, Mascaro C, Tirapu I, Estiarte A, Ciceri F, Lunardi S, et al. ORY-1001, a potent and selective covalent KDM1A inhibitor, for the treatment of acute leukemia. Cancer Cell. 2018;33:495\u2013511.e412.","journal-title":"Cancer Cell"},{"key":"614_CR25","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/ng831","volume":"30","author":"H Karsunky","year":"2002","unstructured":"Karsunky H, Zeng H, Schmidt T, Zevnik B, Kluge R, Schmid KW, et al. Inflammatory reactions and severe neutropenia in mice lacking the transcriptional repressor Gfi1. Nat Genet. 2002;30:295\u2013300.","journal-title":"Nat Genet"},{"key":"614_CR26","doi-asserted-by":"publisher","first-page":"8620","DOI":"10.1002\/anie.201303999","volume":"52","author":"D Ogasawara","year":"2013","unstructured":"Ogasawara D, Itoh Y, Tsumoto H, Kakizawa T, Mino K, Fukuhara K, et al. Lysine-specific demethylase 1-selective inactivators: protein-targeted drug delivery mechanism. Angew Chem. 2013;52:8620\u20134.","journal-title":"Angew Chem"},{"key":"614_CR27","doi-asserted-by":"publisher","first-page":"21007","DOI":"10.18632\/oncotarget.24774","volume":"9","author":"R Yamamoto","year":"2018","unstructured":"Yamamoto R, Kawahara M, Ito S, Satoh J, Tatsumi G, Hishizawa M, et al. Selective dissociation between LSD1 and GFI1B by a LSD1 inhibitor NCD38 induces the activation of ERG super-enhancer in erythroleukemia cells. Oncotarget. 2018;9:21007\u201321.","journal-title":"Oncotarget"},{"key":"614_CR28","doi-asserted-by":"publisher","first-page":"W401","DOI":"10.1093\/nar\/gku410","volume":"42","author":"TG Montague","year":"2014","unstructured":"Montague TG, Cruz JM, Gagnon JA, Church GM, Valen E. CHOPCHOP: a CRISPR\/Cas9 and TALEN web tool for genome editing. Nucleic Acids Res. 2014;42:W401\u20137.","journal-title":"Nucleic Acids Res"},{"key":"614_CR29","doi-asserted-by":"publisher","first-page":"W272","DOI":"10.1093\/nar\/gkw398","volume":"44","author":"K Labun","year":"2016","unstructured":"Labun K, Montague TG, Gagnon JA, Thyme SB, Valen E. CHOPCHOP v2: a web tool for the next generation of CRISPR genome engineering. Nucleic Acids Res. 2016;44:W272\u20136.","journal-title":"Nucleic Acids Res"},{"key":"614_CR30","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34:267\u201373.","journal-title":"Nat Genet"},{"key":"614_CR31","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"key":"614_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen EY, Tan CM, Kou Y, Duan Q, Wang Z, Meirelles GV, et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinform. 2013;14:128.","journal-title":"BMC Bioinform"},{"key":"614_CR33","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov MV, Jones MR, Rouillard AD, Fernandez NF, Duan Q, Wang Z, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44:W90\u20137.","journal-title":"Nucleic Acids Res"},{"key":"614_CR34","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nbt.1754","volume":"29","author":"JT Robinson","year":"2011","unstructured":"Robinson JT, Thorvaldsdottir H, Winckler W, Guttman M, Lander ES, Getz G, et al. Integrative genomics viewer. Nat Biotechnol. 2011;29:24\u20136.","journal-title":"Nat Biotechnol"},{"key":"614_CR35","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/bib\/bbs017","volume":"14","author":"H Thorvaldsdottir","year":"2013","unstructured":"Thorvaldsdottir H, Robinson JT, Mesirov JP. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform. 2013;14:178\u201392.","journal-title":"Brief Bioinform"},{"key":"614_CR36","doi-asserted-by":"publisher","first-page":"W280","DOI":"10.1093\/nar\/gkh355","volume":"32","author":"I Ovcharenko","year":"2004","unstructured":"Ovcharenko I, Nobrega MA, Loots GG, Stubbs L. ECR Browser: a tool for visualizing and accessing data from comparisons of multiple vertebrate genomes. Nucleic Acids Res. 2004;32:W280\u20136.","journal-title":"Nucleic Acids Res"},{"key":"614_CR37","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1101\/gr.229102","volume":"12","author":"WJ Kent","year":"2002","unstructured":"Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, et al. The human genome browser at UCSC. Genome Res. 2002;12:996\u20131006.","journal-title":"Genome Res"},{"key":"614_CR38","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1006\/jmbi.2000.4042","volume":"302","author":"C Notredame","year":"2000","unstructured":"Notredame C, Higgins DG, Heringa J. T-Coffee: a novel method for fast and accurate multiple sequence alignment. J Mol Biol. 2000;302:205\u201317.","journal-title":"J Mol Biol"},{"key":"614_CR39","doi-asserted-by":"publisher","first-page":"D142","DOI":"10.1093\/nar\/gkt997","volume":"42","author":"A Mathelier","year":"2014","unstructured":"Mathelier A, Zhao X, Zhang AW, Parcy F, Worsley-Hunt R, Arenillas DJ, et al. JASPAR 2014: an extensively expanded and updated open-access database of transcription factor binding profiles. Nucleic Acids Res. 2014;42:D142\u20137.","journal-title":"Nucleic Acids Res"},{"key":"614_CR40","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1111\/j.1365-2141.1995.tb05391.x","volume":"91","author":"K Tohyama","year":"1995","unstructured":"Tohyama K, Tohyama Y, Nakayama T, Ueda T, Nakamura T, Yoshida Y. A novel factor-dependent human myelodysplastic cell line, MDS92, contains haemopoietic cells of several lineages. Br J Haematol. 1995;91:795\u20139.","journal-title":"Br J Haematol"},{"key":"614_CR41","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391\u2013405.","journal-title":"Blood"},{"key":"614_CR42","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1101\/gad.959102","volume":"16","author":"S Saleque","year":"2002","unstructured":"Saleque S, Cameron S, Orkin SH. The zinc-finger proto-oncogene Gfi-1b is essential for development of the erythroid and megakaryocytic lineages. Genes Dev. 2002;16:301\u20136.","journal-title":"Genes Dev"},{"key":"614_CR43","doi-asserted-by":"publisher","first-page":"10141","DOI":"10.1073\/pnas.0900437106","volume":"106","author":"X Hu","year":"2009","unstructured":"Hu X, Li X, Valverde K, Fu X, Noguchi C, Qiu Y, et al. LSD1-mediated epigenetic modification is required for TAL1 function and hematopoiesis. Proc Natl Acad Sci USA. 2009;106:10141\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"614_CR44","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1182\/blood.V97.5.1314","volume":"97","author":"P Kastner","year":"2001","unstructured":"Kastner P, Lawrence HJ, Waltzinger C, Ghyselinck NB, Chambon P, Chan S. Positive and negative regulation of granulopoiesis by endogenous RARalpha. Blood. 2001;97:1314\u201320.","journal-title":"Blood"},{"key":"614_CR45","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.ccr.2010.03.022","volume":"17","author":"Y Kamikubo","year":"2010","unstructured":"Kamikubo Y, Zhao L, Wunderlich M, Corpora T, Hyde RK, Paul TA, et al. Accelerated leukemogenesis by truncated CBF beta-SMMHC defective in high-affinity binding with RUNX1. Cancer Cell. 2010;17:455\u201368.","journal-title":"Cancer Cell"},{"key":"614_CR46","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1365-2184.2010.00679.x","volume":"43","author":"AF da Cunha","year":"2010","unstructured":"da Cunha AF, Brugnerotto AF, Duarte AS, Lanaro C, Costa GG, Saad ST, et al. Global gene expression reveals a set of new genes involved in the modification of cells during erythroid differentiation. Cell Prolif. 2010;43:297\u2013309.","journal-title":"Cell Prolif"},{"key":"614_CR47","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1182\/blood-2004-04-1603","volume":"104","author":"JJ Welch","year":"2004","unstructured":"Welch JJ, Watts JA, Vakoc CR, Yao Y, Wang H, Hardison RC, et al. Global regulation of erythroid gene expression by transcription factor GATA-1. Blood. 2004;104:3136\u201347.","journal-title":"Blood"},{"key":"614_CR48","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1056\/NEJMoa040465","volume":"350","author":"PJ Valk","year":"2004","unstructured":"Valk PJ, Verhaak RG, Beijen MA, Erpelinck CA, Barjesteh van Waalwijk van Doorn-Khosrovani S, Boer JM, et al. Prognostically useful gene-expression profiles in acute myeloid leukemia. N Engl J Med. 2004;350:1617\u201328.","journal-title":"N Engl J Med"},{"key":"614_CR49","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1016\/j.cell.2015.11.013","volume":"163","author":"F Paul","year":"2015","unstructured":"Paul F, Arkin Y, Giladi A, Jaitin DA, Kenigsberg E, Keren-Shaul H, et al. Transcriptional heterogeneity and lineage commitment in myeloid progenitors. Cell. 2015;163:1663\u201377.","journal-title":"Cell"},{"key":"614_CR50","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.molcel.2007.06.039","volume":"27","author":"S Saleque","year":"2007","unstructured":"Saleque S, Kim J, Rooke HM, Orkin SH. Epigenetic regulation of hematopoietic differentiation by Gfi-1 and Gfi-1b is mediated by the cofactors CoREST and LSD1. Mol Cell. 2007;27:562\u201372.","journal-title":"Mol Cell"},{"key":"614_CR51","doi-asserted-by":"publisher","first-page":"7420","DOI":"10.1073\/pnas.112008599","volume":"99","author":"MA Hakimi","year":"2002","unstructured":"Hakimi MA, Bochar DA, Chenoweth J, Lane WS, Mandel G, Shiekhattar R. A core-BRAF35 complex containing histone deacetylase mediates repression of neuronal-specific genes. Proc Natl Acad Sci USA. 2002;99:7420\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"614_CR52","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1158\/1535-7163.MCT-16-0471","volume":"16","author":"Y Ishikawa","year":"2017","unstructured":"Ishikawa Y, Gamo K, Yabuki M, Takagi S, Toyoshima K, Nakayama K, et al. A novel LSD1 inhibitor T-3775440 disrupts GFI1B-containing complex leading to transdifferentiation and impaired growth of AML cells. Mol Cancer Ther. 2017;16:273\u201384.","journal-title":"Mol Cancer Ther"},{"key":"614_CR53","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1182\/blood-2017-09-807024","volume":"131","author":"M Cusan","year":"2018","unstructured":"Cusan M, Cai SF, Mohammad HP, Krivtsov A, Chramiec A, Loizou E, et al. LSD1 inhibition exerts its antileukemic effect by recommissioning PU.1- and C\/EBPalpha-dependent enhancers in AML. Blood. 2018;131:1730\u201342.","journal-title":"Blood"},{"key":"614_CR54","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.ccr.2013.11.003","volume":"24","author":"B Chapuy","year":"2013","unstructured":"Chapuy B, McKeown MR, Lin CY, Monti S, Roemer MG, Qi J, et al. Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma. Cancer Cell. 2013;24:777\u201390.","journal-title":"Cancer Cell"},{"key":"614_CR55","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.cell.2013.03.036","volume":"153","author":"J Loven","year":"2013","unstructured":"Loven J, Hoke HA, Lin CY, Lau A, Orlando DA, Vakoc CR, et al. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell. 2013;153:320\u201334.","journal-title":"Cell"},{"key":"614_CR56","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.ccr.2014.02.008","volume":"25","author":"H Yamazaki","year":"2014","unstructured":"Yamazaki H, Suzuki M, Otsuki A, Shimizu R, Bresnick EH, Engel JD, et al. A remote GATA2 hematopoietic enhancer drives leukemogenesis in inv(3)(q21;q26) by activating EVI1 expression. Cancer Cell. 2014;25:415\u201327.","journal-title":"Cancer Cell"},{"key":"614_CR57","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/ng1361","volume":"36","author":"F Rosenbauer","year":"2004","unstructured":"Rosenbauer F, Wagner K, Kutok JL, Iwasaki H, Le Beau MM, Okuno Y, et al. Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1. Nat Genet. 2004;36:624\u201330.","journal-title":"Nat Genet"},{"key":"614_CR58","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1038\/ng1898","volume":"38","author":"U Steidl","year":"2006","unstructured":"Steidl U, Rosenbauer F, Verhaak RG, Gu X, Ebralidze A, Otu HH, et al. Essential role of Jun family transcription factors in PU.1 knockdown-induced leukemic stem cells. Nat Genet. 2006;38:1269\u201377.","journal-title":"Nat Genet"},{"key":"614_CR59","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1158\/2159-8290.CD-19-0106","volume":"9","author":"C Duy","year":"2019","unstructured":"Duy C, Teater M, Garrett-Bakelman FE, Lee TC, Meydan C, Glass JL, et al. Rational targeting of cooperating layers of the epigenome yields enhanced therapeutic efficacy against AML. Cancer Discov. 2019;9:872\u201389.","journal-title":"Cancer Discov"},{"key":"614_CR60","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1038\/leu.2014.119","volume":"28","author":"W Fiskus","year":"2014","unstructured":"Fiskus W, Sharma S, Shah B, Portier BP, Devaraj SG, Liu K, et al. Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells. Leukemia. 2014;28:2155\u201364.","journal-title":"Leukemia"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-019-0614-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-019-0614-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-019-0614-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,17]],"date-time":"2022-04-17T06:05:27Z","timestamp":1650175527000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-019-0614-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,1]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["614"],"URL":"https:\/\/doi.org\/10.1038\/s41375-019-0614-6","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,1]]},"assertion":[{"value":"1 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}